AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: arnie h who wrote (1809)	3/31/2005 1:25:13 PM
From: richardred	Read Replies (1) of 2173

>My guess is concern over lack of full approval at this time. Arnie: This was close to my guess, in an earlier post. One thing I find interesting now. The stock is trading below Lilly's exercise price. Lilly has the option of an equity investment instead of milestone payments only. It will be interesting to see what Lilly's action is, if the approval is delayed. I wouldn't be surprised to see them buy share blocks in the open market as long as the stock trades below 18. A 13d filing by them in a month or two, would confirm my guess. A non approval letter would be a disaster, but IMO that's remote. Still the continuing studies of Symlin as a weight loss option adds speculative fever down the road.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next